A year later, as we read and watch the breathless coverage devoted to recent moves by Google, Microsoft, and Apple, we are left asking "is healthcare IT worth the hype?"
July 2008
Advertisement
Advertisement
Trending on HCPLive
1
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
2
From Injectable to Oral: Optimal Durable Clearance Across the IL-23 Class
3
Ritlecitinib Stabilizes Vitiligo in Tranquillo Trial, With Iltefat Hamzavi, MD
4
Advances in Treating High-Impact Psoriasis from EADV 2026
5